Clinical Trial Update: Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing adjuvant sequential versus combined taxane-based chemotherapy followed by different biological therapies in early HER2-positive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED